<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39347295</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Slowly Progressive Rhabdomyolysis Post COVID-19: Insights for Acute Kidney Injury Prediction With Discordant Creatine Kinase and Myoglobin Elevations.</ArticleTitle><Pagination><StartPage>e68145</StartPage><MedlinePgn>e68145</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e68145</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.68145</ELocationID><Abstract><AbstractText>Rhabdomyolysis can lead to acute kidney injury (AKI), primarily due to myoglobin-induced tubular damage. We present a case of slowly progressive rhabdomyolysis following SARS-CoV-2 infection in a 28-year-old male who was monitored through serial serum creatine kinase (CK) and myoglobin levels. Despite prominent CK elevations, the patient did not develop AKI, probably due to disproportionately mild serum myoglobin elevation with distinctive cyclic spikes. This case underscores the informative value of frequent monitoring of both CK and myoglobin to assess muscle damage severity and AKI risk in rhabdomyolysis, particularly with viral infections like COVID-19 that can cause delayed-onset muscle injury.</AbstractText><CopyrightInformation>Copyright © 2024, Okubo et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Okubo</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kouzu</LastName><ForeName>Hidemichi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamada</LastName><ForeName>Ayaka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Endo</LastName><ForeName>Kota</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawaharata</LastName><ForeName>Wataru</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohwada</LastName><ForeName>Wataru</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suda</LastName><ForeName>Kentaro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Clinical Genetics, Sapporo Medical University Hospital, Sapporo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagano</LastName><ForeName>Nobutaka</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakurai</LastName><ForeName>Ayami</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koyama</LastName><ForeName>Masayuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furuhashi</LastName><ForeName>Masato</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, JPN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">creatine kinase</Keyword><Keyword MajorTopicYN="N">myoglobin</Keyword><Keyword MajorTopicYN="N">rhabdomyolysis</Keyword><Keyword MajorTopicYN="N">sars-cov-2</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39347295</ArticleId><ArticleId IdType="pmc">PMC11438541</ArticleId><ArticleId IdType="doi">10.7759/cureus.68145</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The syndrome of rhabdomyolysis: pathophysiology and diagnosis. Giannoglou GD, Chatzizisis YS, Misirli G. Eur J Intern Med. 2007;18:90–100.</Citation><ArticleIdList><ArticleId IdType="pubmed">17338959</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis and acute kidney injury. Bosch X, Poch E, Grau JM. N Engl J Med. 2009;361:62–72.</Citation><ArticleIdList><ArticleId IdType="pubmed">19571284</ArticleId></ArticleIdList></Reference><Reference><Citation>A risk prediction score for kidney failure or mortality in rhabdomyolysis. McMahon GM, Zeng X, Waikar SS. JAMA Intern Med. 2013;173:1821–1828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5152583</ArticleId><ArticleId IdType="pubmed">24000014</ArticleId></ArticleIdList></Reference><Reference><Citation>Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Lappalainen H, Tiula E, Uotila L, Mänttäri M. Crit Care Med. 2002;30:2212–2215.</Citation><ArticleIdList><ArticleId IdType="pubmed">12394946</ArticleId></ArticleIdList></Reference><Reference><Citation>Peak value of blood myoglobin predicts acute renal failure induced by rhabdomyolysis. Kasaoka S, Todani M, Kaneko T, Kawamura Y, Oda Y, Tsuruta R, Maekawa T. J Crit Care. 2010;25:601–604.</Citation><ArticleIdList><ArticleId IdType="pubmed">20537502</ArticleId></ArticleIdList></Reference><Reference><Citation>Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute inflammation. Bass DA, Gonwa TA, Szejda P, Cousart MS, DeChatelet LR, McCall CE. J Clin Invest. 1980;65:1265–1271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC371463</ArticleId><ArticleId IdType="pubmed">7410543</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis as a consequence of adrenal insufficiency. de Witte SA, Bonnet F, Morlat P, Beylot J. Am J Med. 2003;114:160.</Citation><ArticleIdList><ArticleId IdType="pubmed">12586241</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypothyroid myopathy: a peculiar clinical presentation of thyroid failure. Review of the literature. Sindoni A, Rodolico C, Pappalardo MA, Portaro S, Benvenga S. Rev Endocr Metab Disord. 2016;17:499–519.</Citation><ArticleIdList><ArticleId IdType="pubmed">27154040</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe rhabdomyolysis following a viral illness: a case report and review of the literature. Pesik NT, Otten EJ. J Emerg Med. 1996;14:425–428.</Citation><ArticleIdList><ArticleId IdType="pubmed">8842914</ArticleId></ArticleIdList></Reference><Reference><Citation>Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection. Hannah JR, Ali SS, Nagra D, Adas MA, Buazon AD, Galloway JB, Gordon PA. Clin Exp Rheumatol. 2022;40:329–338.</Citation><ArticleIdList><ArticleId IdType="pubmed">35225218</ArticleId></ArticleIdList></Reference><Reference><Citation>Relationship between rhabdomyolysis and SARS-CoV-2 disease severity. Samardzic T, Muradashvili T, Guirguis S, Felek S, Pan SC, Tiyyagura S, Feinn R. Cureus. 2024;16:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10895313</ArticleId><ArticleId IdType="pubmed">38410346</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis in COVID-19 patients: a retrospective observational study. Haroun MW, Dieiev V, Kang J, et al. Cureus. 2021;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869906</ArticleId><ArticleId IdType="pubmed">33575135</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis as potential late complication associated with COVID-19. Jin M, Tong Q. Emerg Infect Dis. 2020;26:1618–1620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323559</ArticleId><ArticleId IdType="pubmed">32197060</ArticleId></ArticleIdList></Reference><Reference><Citation>Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. N Engl J Med. 2009;361:680–689.</Citation><ArticleIdList><ArticleId IdType="pubmed">19564631</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis associated with 2009 influenza A(H1N1) Ayala E, Kagawa FT, Wehner JH, Tam J, Upadhyay D. JAMA. 2009;302:1863–1864.</Citation><ArticleIdList><ArticleId IdType="pubmed">19887664</ArticleId></ArticleIdList></Reference><Reference><Citation>Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. Aschman T, Schneider J, Greuel S, et al. JAMA Neurol. 2021;78:948–960.</Citation><ArticleIdList><ArticleId IdType="pubmed">34115106</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum creatine kinase as predictor of clinical course in rhabdomyolysis: a 5-year intensive care survey. de Meijer AR, Fikkers BG, de Keijzer MH, van Engelen BG, Drenth JP. Intensive Care Med. 2003;29:1121–1125.</Citation><ArticleIdList><ArticleId IdType="pubmed">12768237</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis: a 10-year retrospective study of patients treated in a medical department. Vangstad M, Bjornaas MA, Jacobsen D. Eur J Emerg Med. 2019;26:199–204.</Citation><ArticleIdList><ArticleId IdType="pubmed">29068810</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure. Wakabayashi Y, Kikuno T, Ohwada T, Kikawada R. Intensive Care Med. 1994;20:109–112.</Citation><ArticleIdList><ArticleId IdType="pubmed">8201089</ArticleId></ArticleIdList></Reference><Reference><Citation>Absence of myoglobinuria in acute psychotic patients with marked elevation in serum creatine phosphokinase level. Hermesh H, Manor I, Shiloh R, Weizman R, Munitz H. Eur Neuropsychopharmacol. 2001;11:111–115.</Citation><ArticleIdList><ArticleId IdType="pubmed">11313156</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>